Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 15, 2026
DataAggregated Company Financials
Companies6
- 7D2.0%
- 3M-27.0%
- 1Y-23.7%
- YTDn/a
The Drug Retail industry is up 2.0% in the last week, with JD Health International up 0.5%. In the past year, the industry is down 24%. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 15 Jul 2026 | HK$190.6b | HK$142.9b | HK$8.7b | 30.2x | 21.9x | 1.3x |
| Fri, 12 Jun 2026 | HK$198.7b | HK$143.0b | HK$8.7b | 33.4x | 22.8x | 1.4x |
| Sun, 10 May 2026 | HK$248.3b | HK$140.9b | HK$8.7b | 43.8x | 28.7x | 1.8x |
| Tue, 07 Apr 2026 | HK$263.3b | HK$139.4b | HK$8.6b | 46.6x | 30.7x | 1.9x |
| Thu, 05 Mar 2026 | HK$276.3b | HK$129.5b | HK$6.9b | 37.7x | 39.8x | 2.1x |
| Sat, 31 Jan 2026 | HK$346.5b | HK$128.5b | HK$6.9b | 48.6x | 50.4x | 2.7x |
| Mon, 29 Dec 2025 | HK$308.4b | HK$126.9b | HK$6.8b | 38.8x | 45.4x | 2.4x |
| Wed, 26 Nov 2025 | HK$334.1b | HK$122.9b | HK$6.2b | 61.3x | 54.1x | 2.7x |
| Fri, 24 Oct 2025 | HK$334.8b | HK$122.1b | HK$6.1b | 61.2x | 54.5x | 2.7x |
| Sun, 21 Sep 2025 | HK$382.4b | HK$122.3b | HK$6.1b | 68.4x | 62.2x | 3.1x |
| Tue, 19 Aug 2025 | HK$348.7b | HK$122.5b | HK$5.1b | 57x | 68.4x | 2.8x |
| Thu, 17 Jul 2025 | HK$252.0b | HK$115.4b | HK$4.5b | 47.5x | 55.9x | 2.2x |
| Sat, 14 Jun 2025 | HK$230.0b | HK$115.3b | HK$4.5b | 47.4x | 51.1x | 2x |
| Mon, 12 May 2025 | HK$223.4b | HK$111.0b | HK$4.2b | 61.8x | 53.4x | 2x |
| Wed, 09 Apr 2025 | HK$179.8b | HK$109.3b | HK$4.1b | 51.6x | 43.6x | 1.6x |
| Fri, 07 Mar 2025 | HK$245.1b | HK$104.2b | HK$3.6b | 58.6x | 67.9x | 2.4x |
| Sun, 02 Feb 2025 | HK$178.0b | HK$104.4b | HK$3.6b | 40.6x | 49.3x | 1.7x |
| Tue, 31 Dec 2024 | HK$156.1b | HK$103.3b | HK$3.6b | 37.3x | 43.6x | 1.5x |
| Thu, 28 Nov 2024 | HK$169.4b | HK$104.4b | HK$3.6b | 38.6x | 46.9x | 1.6x |
| Sat, 26 Oct 2024 | HK$173.9b | HK$104.5b | HK$3.3b | 49x | 52.4x | 1.7x |
| Mon, 23 Sep 2024 | HK$147.5b | HK$105.9b | HK$3.4b | 39.8x | 43.9x | 1.4x |
| Wed, 21 Aug 2024 | HK$135.9b | HK$104.7b | HK$3.0b | 37.4x | 45.5x | 1.3x |
| Fri, 19 Jul 2024 | HK$141.3b | HK$102.0b | HK$2.4b | 43.4x | 59.1x | 1.4x |
| Sun, 16 Jun 2024 | HK$154.4b | HK$102.1b | HK$2.4b | 46.6x | 64.6x | 1.5x |
| Tue, 14 May 2024 | HK$168.3b | HK$103.7b | HK$2.3b | 50.1x | 72.4x | 1.6x |
| Thu, 11 Apr 2024 | HK$148.8b | HK$104.0b | HK$2.3b | 44.2x | 63.8x | 1.4x |
| Sat, 09 Mar 2024 | HK$162.1b | HK$105.1b | -HK$1,456,481,797.74 | 53.7x | -111.3x | 1.5x |
| Mon, 05 Feb 2024 | HK$148.4b | HK$105.1b | -HK$1,456,303,487.00 | 48.1x | -101.9x | 1.4x |
| Wed, 03 Jan 2024 | HK$205.7b | HK$105.8b | -HK$1,465,904,217.00 | 63.9x | -140.3x | 1.9x |
| Fri, 01 Dec 2023 | HK$206.6b | HK$105.7b | -HK$1,465,280,878.00 | 65.2x | -141x | 2x |
| Sun, 29 Oct 2023 | HK$205.0b | HK$101.7b | -HK$1,734,606,974.00 | 86x | -118.2x | 2x |
| Tue, 26 Sep 2023 | HK$227.9b | HK$102.2b | -HK$1,672,657,299.00 | 101.3x | -136.2x | 2.2x |
| Thu, 24 Aug 2023 | HK$221.0b | HK$102.5b | -HK$2,687,970,921.00 | 72.6x | -82.2x | 2.2x |
| Sat, 22 Jul 2023 | HK$270.4b | HK$96.3b | -HK$4,178,456,975.00 | 117.6x | -64.7x | 2.8x |
Price to Earnings Ratio
-64.7x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 21.9x which is lower than its 3-year average PE of 98.2x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.14% | |
| Consumer Staples | 1.41% | |
| Food and Staples Retail | 2.73% | |
| Drug Retail | 1.97% | |
| Big Box Super Stores | 5.54% | |
| Food Retail | 3.94% | |
| Food Distributors | -0.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$37.52 | 0.5% +HK$637.9m | -17.8% | PE19.2x | |
| 6086 Fangzhou | HK$0.84 | 12.0% +HK$124.7m | -78.8% | PE85x |